Perindopril Erbumine (Lupin Pharmaceuticals, Inc)
Welcome to the PulseAid listing for the Perindopril Erbumine drug offered from Lupin Pharmaceuticals, Inc. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lupin Pharmaceuticals, Inc |
| NON-PROPRIETARY NAME: | Perindopril Erbumine |
| SUBSTANCE NAME: | PERINDOPRIL ERBUMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-03-15 |
| END MARKETING DATE: | 0000-00-00 |
Perindopril Erbumine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Perindopril Erbumine from Lupin Pharmaceuticals, Inc |
| LABELER NAME: | Lupin Pharmaceuticals, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/1) |
| START MARKETING DATE: | 2010-03-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68180-235_fbb31482-9ac8-48c6-b814-5d467f22051b |
| PRODUCT NDC: | 68180-235 |
| APPLICATION NUMBER: | ANDA078263 |
Other PERINDOPRIL ERBUMINE Pharmaceutical Manufacturers / Labelers:
